Goodman John B 4
4 · Proto Labs Inc · Filed Mar 16, 2018
Insider Transaction Report
Form 4
Proto Labs IncPRLB
Goodman John B
Director
Transactions
- Exercise/Conversion
Common Stock
2018-03-14$70.00/sh+537$37,590→ 11,628 total - Sale
Common Stock
2018-03-14$122.71/sh−1,114$136,700→ 10,514 total - Exercise/Conversion
Common Stock
2018-03-14$62.68/sh+577$36,166→ 11,091 total - Exercise/Conversion
Stock Option (right to buy)
2018-03-14−577→ 1,154 totalExercise: $62.68Exp: 2024-05-19→ Common Stock (577 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-03-14−537→ 1,072 totalExercise: $70.00Exp: 2025-05-19→ Common Stock (537 underlying)
Footnotes (4)
- [F1]Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018.
- [F2]Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018.
- [F3]Reflects the weighted average price of 1,114 shares of common stock of Proto Labs, Inc. sold by the reporting person on March 14, 2018 with sale prices ranging from $122.50 to $123.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]Fully vested.